Roger Pomerantz
Chairman presso VIRACTA THERAPEUTICS, INC.
Patrimonio netto: 101 363 $ in data 31/03/2024
Profilo
Roger James Pomerantz is currently the Chairman at CollPlant Biotechnologies Ltd., Silicon INSITE, Inc., Viracta Subsidiary, Inc., and Indaptus Therapeutics, Inc. He is also the Vice Chairman at Enlivex Therapeutics Ltd.
Additionally, he holds positions as a Director at Silicon Therapeutics, Inc., X-Vax Technology, Inc., and Verimmune, Inc. Furthermore, he is an Independent Director at Aprinoia Therapeutics, Inc. and the President of Pomerantz Life Sciences Consulting Group LLC.
In his former roles, Dr. Pomerantz served as the President & Chief Executive Officer of Tibotec Pharmaceuticals and as the Chairman of Sunesis Pharmaceuticals, Inc. He was also the Chairman of the Institute of Human Virology from 2002 to 2005.
Additionally, he held the position of Chairman at ContraFect Corp.
in 2023, Seres Therapeutics, Inc. in 2019, and Rubius Therapeutics, Inc. from 2014 to 2019.
He was the Senior VP & Head-Licensing & Acquisitions at Merck & Co., Inc. from 2011 to 2013.
Moreover, he served as the President of Janssen R&D Ireland Ltd.
from 2005 to 2010 and as the Global Head-Infectious Diseases at Johnson & Johnson Pharmaceutical Group from 2005 to 2010.
Dr. Pomerantz's education includes an undergraduate degree from The Johns Hopkins University and a doctorate from The Johns Hopkins University School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
25/02/2024 | 99 375 ( 0.25% ) | 101 363 $ | 31/03/2024 | |
CONTRAFECT CORP.
0.00% | 06/09/2023 | 1 ( 0.00% ) | 0 $ | 31/03/2024 |
25/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
15/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Roger Pomerantz
Società | Posizione | Inizio |
---|---|---|
COLLPLANT BIOTECHNOLOGIES LTD. | Chairman | 10/02/2020 |
VIRACTA THERAPEUTICS, INC. | Chairman | 01/09/2020 |
INDAPTUS THERAPEUTICS, INC. | Chairman | 01/08/2021 |
ENLIVEX THERAPEUTICS LTD. | Director/Board Member | 23/05/2022 |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Chairman | 14/09/2020 |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Chairman | 08/07/2019 |
Pomerantz Life Sciences Consulting Group LLC | President | - |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Director/Board Member | - |
Precedenti posizioni note di Roger Pomerantz
Società | Posizione | Fine |
---|---|---|
CONTRAFECT CORPORATION | Chief Executive Officer | 15/11/2023 |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Roger Pomerantz
The Johns Hopkins University | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 9 |
---|---|
MERCK & CO., INC. | Health Technology |
MOLECULAR PHARMACOLOGY (USA), LTD. | Commercial Services |
CONTRAFECT CORPORATION | Health Technology |
COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
SERES THERAPEUTICS, INC. | Health Technology |
EVELO BIOSCIENCES, INC. | Health Technology |
ENLIVEX THERAPEUTICS LTD. | Health Technology |
VIRACTA THERAPEUTICS, INC. | Health Technology |
INDAPTUS THERAPEUTICS, INC. | Health Technology |
Aziende private | 14 |
---|---|
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Janssen R&D Ireland Ltd. | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Consumer Services |
Johnson & Johnson Pharmaceutical Group | |
Tibotec Pharmaceuticals | |
Intec Pharma Ltd.
Intec Pharma Ltd. Pharmaceuticals: MajorHealth Technology Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of drugs based on proprietary Accordion Pill platform technology. Its Accordion Pill technology is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs under development by utilizing an efficient gastric retention and specific release mechanism. The company was founded by Zvika Joseph on October 23, 2000 and is headquartered in Jerusalem, Israel. | Health Technology |
Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Health Technology |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
Janssen Therapeutics, Inc. | |
Pomerantz Life Sciences Consulting Group LLC |
- Borsa valori
- Insiders
- Roger Pomerantz